Evaluate the efficacy of VNT-101 and other compounds against highly pathogenic avian influenza (HPAI) viruses in vitro and in vivo

Project: Research project

Project Details

StatusActive
Effective start/end date1/1/25 → 12/31/26

Funding

  • Novo Nordisk Fonden ( Award #NNF24SA0097217): $652,730.00